Coronavirus Pandemic

1.1 billion India-made Covid vaccine doses under new COVAX scheme supply deal

Reuters/New Delhi
Filed on February 3, 2021

(Reuters file)

UNICEF chief said the shots would be delivered over a number of years for low and middle-income countries.

India's Serum Institute will supply 1.1 billion doses of Covid-19 vaccines developed by AstraZeneca and Novavax to the COVAX vaccine scheme as part of a new long-term deal, head of the UN Children's Fund said on Wednesday.

UNICEF chief Henrietta Fore said the shots would be delivered over a number of years at the cost of about $3 per dose for low- and middle-income countries.

They would be produced by Serum under a technology transfer agreement, she said in a briefing.

The COVAX facility is co-led by GAVI, the World Health Organization, the Coalition for Epidemic Preparedness Innovations and UNICEF.

ERROR: Macro /ads/dfp-ad-article-new is missing!
MORE FROM Coronavirus Pandemic
MORE FROM Khaleej Times
CurrentRequestUnmodified: /apps/pbcs.dll/article?avis=KT&date=20210921&category=ARTICLE&lopenr=210929798&Ref=AR&_gl=1*1jotsr5*_ga*UlBfX05lcVVFdkRQR1ZBdkNjN2RKUnlyTDByT251S0o5eHN3ci1Dd3p3MGN2anpfb2pLeUlXd0lXQl8tc2x2Wg&profile=1913 macro_action: article, macro_profile: ,1913,1000 macro_adspot:
KT App Download
khaleejtimes app

All new KT app
is available
for download:

khaleejtimes - android khaleejtimes - ios khaleejtimes - HUAWEI AppGallery